Table 2.
Patients and disease characteristics of AKI types (CA-AKI and HA-AKI)
| Variables | CA-AKI (n = 111) | HA-AKI (n = 89) | p-value (Pearson χ2/Fisher's exact test) |
|---|---|---|---|
| Comorbid conditions | |||
| DM, n (%) | 21 (18.9) | 37 (41.6) | 0.34 |
| Hypertension, n (%) | 10 (9.0) | 17 (19.1) | 0.059 |
| Cardiovascular disease, n (%) | 11 (9.9) | 26 (29.2) | 0.0001 |
| Cerebrovascular event, n (%) | 5 (4.5) | 9 (10.1) | 0.12 |
| Liver diseases, n (%) | 8 (7.2) | 7 (7.9) | 0.009 |
| Malignancy, n (%) | 11 (9.9) | 3 (3.4) | 0.07 |
| COPD, n (%) | 8 (7.2) | 1 (1.1) | 0.045 |
| Thyroid disorders, n (%) | 2 (1.8) | 4 (4.5) | 0.41 |
| Urinary system, n (%) | 4 (3.6) | 5 (5.6) | 0.51 |
| Others, n (%) | 6 (5.4) | 3 (3.4) | 0.73 |
| Age-groups | |||
| <30 years, n (%) | 10 (9) | 10 (11.2) | 0.19 |
| 30–60 years, n (%) | 58 (52.3) | 35 (39.3) | 0.06 |
| >60 years, n (%) | 43 (38.7) | 44 (49.4) | 0.13 |
| Etiology | |||
| Sepsis, n (%) | 31 (27.9) | 35 (39.3) | 0.08 |
| Infections, n (%) | 48 (43.2) | 17 (19.1) | 0.0003 |
| Post-surgery, n (%) | 9 (8.1) | 46 (51.7) | <0.0001 |
| Cardiovascular disease, n (%) | 5 (4.5) | 2 (2.2) | 0.38 |
| Liver disease, n (%) | 13 (11.7) | 0 | 0.001 |
| Drug induced, n (%) | 9 (8.1) | 2 (2.2) | 0.11 |
| Poisoning, n (%) | 10 (9) | 0 | 0.003 |
| Malignancy, n (%) | 7 (6.3) | 0 | 0.01 |
| Alcohol abuse, n (%) | 5 (4.5) | 0 | 0.06 |
| Neurological, n (%) | 13 (11.7) | 21 (23.6) | 0.02 |
| RRT requirement (>30 days) | |||
| RRT >30 days, n (%) | 6 (5.4) | 9 (10.1) | 0.2 |
AKI, acute kidney injury; CA-AKI, community acquired AKI; COPD, chronic obstructive pulmonary disease; DM, diabetes mellitus; HA-AKI, hospital acquired AKI; RRT, renal replacement therapy